Fara Brasó-Maristany (Fara Brasó Maristany)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Venues

Nature communications

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of the National Cancer Institute

JCO precision oncology

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

King's College London - Guy's Campus (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Nov 02 2017

Spain

Postdoctoral fellow :: Oncology

King's College London

United Kingdom

Research Associate :: Cancer Studies

Education History

King's College London - Guy's Campus

United Kingdom

PHD :: Division of Cancer Studies

Publications

Antonio Llombart, José Pérez-García, Fara Brasó-Maristany, Laia Paré, Guillermo Villacampa, Maria Gion, Peter Schmid, Marco Colleoni, Manuel Ruiz Borrego, Patricia Galván, Joel S Parker, Wesley Buckingham, Charles M Perou, Patricia Villagrasa, Jose Antonio Guerrero, Miguel Sampayo, Mario Mancino, Aleix Prat, Javier Cortes
HER2DX Genomic Assay in HER2-positive Early Breast Cancer Treated with Trastuzumab and Pertuzumab: A Correlative Analysis from PHERGain Phase II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Fara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, Adrienne G Waks, Juan Miguel Cejalvo, Mireia Margelí, Pablo Tolosa, Francisco Javier Salvador-Bofill, Josefina Cruz, Blanca González-Farré, Esther Sanfeliu, Andreu Òdena, Violeta Serra, Francisco J Pardo-Palacios, Ana María Luna Barrera, Miriam Arumi, Juan Antonio Guerra, Guillermo Villacampa, Rodrigo Sánchez-Bayona, Eva Ciruelos, Martín Espinosa-Bravo, Yann Izarzugaza, Patricia Galván, Judith Matito, Sonia Pernas, María Jesús Vidal Losada, Anu Santhanagopal, Dalila Sellami, Stephen Esker, Pang-Dian Fan, Fumitaka Suto, Ana Vivancos, Tomás Pascual, Aleix Prat, Mafalda Oliveira
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response. Nature communications 15 (1) (2024)
Leonard Schmiester, Fara Brasó-Maristany, Blanca Gonzalez-Farre, Tomás Pascual, Joaquín Gavilá, Xavier Tekpli, Jürgen Geisler, Vessela N Kristensen, Arnoldo Frigessi, Aleix Prat, Alvaro Köhn-Luque
Computational Model Predicts Patient Outcomes in Luminal B Breast Cancer Treated with Endocrine Therapy and CDK4/6 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Fara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, Adrienne G Waks, Juan Miguel Cejalvo, Mireia Margelí, Pablo Tolosa, Francisco Javier Salvador-Bofill, Josefina Cruz, Blanca González-Farré, Esther Sanfeliu, Andreu Òdena, Violeta Serra, Francisco J Pardo-Palacios, Ana María Luna Barrera, Miriam Arumi, Juan Antonio Guerra, Guillermo Villacampa, Rodrigo Sánchez-Bayona, Eva Ciruelos, Martín Espinosa-Bravo, Yann Izarzugaza, Patricia Galván, Judith Matito, Sonia Pernas, María Jesús Vidal Losada, Anu Santhanagopal, Dalila Sellami, Stephen Esker, Pang-Dian Fan, Fumitaka Suto, Ana Vivancos, Tomás Pascual, Aleix Prat, Mafalda Oliveira
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response. Nature communications 15 (1) (2024)
Irene Andreu-Saumell, Alba Rodriguez-Garcia, Vanessa Mühlgrabner, Marta Gimenez-Alejandre, Berta Marzal, Joan Castellsagué, Fara Brasó-Maristany, Hugo Calderon, Laura Angelats, Salut Colell, Mara Nuding, Marta Soria-Castellano, Paula Barbao, Aleix Prat, Alvaro Urbano-Ispizua, Johannes B Huppa, Sonia Guedan
CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition. Nature communications 15 (1) (2024)
Irene Andreu-Saumell, Alba Rodriguez-Garcia, Vanessa Mühlgrabner, Marta Gimenez-Alejandre, Berta Marzal, Joan Castellsagué, Fara Brasó-Maristany, Hugo Calderon, Laura Angelats, Salut Colell, Mara Nuding, Marta Soria-Castellano, Paula Barbao, Aleix Prat, Alvaro Urbano-Ispizua, Johannes B Huppa, Sonia Guedan
CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition. Nature communications 15 (1) (2024)
Fara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, Adrienne G Waks, Juan Miguel Cejalvo, Mireia Margelí, Pablo Tolosa, Francisco Javier Salvador-Bofill, Josefina Cruz, Blanca González-Farré, Esther Sanfeliu, Andreu Òdena, Violeta Serra, Francisco J Pardo-Palacios, Ana María Luna Barrera, Miriam Arumi, Juan Antonio Guerra, Guillermo Villacampa, Rodrigo Sánchez-Bayona, Eva Ciruelos, Martín Espinosa-Bravo, Yann Izarzugaza, Patricia Galván, Judith Matito, Sonia Pernas, María Jesús Vidal Losada, Anu Santhanagopal, Dalila Sellami, Stephen Esker, Pang-Dian Fan, Fumitaka Suto, Ana Vivancos, Tomás Pascual, Aleix Prat, Mafalda Oliveira
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response. Nature communications 15 (1) (2024)
Leonard Schmiester, Fara Brasó-Maristany, Blanca Gonzalez-Farre, Tomás Pascual, Joaquín Gavilá, Xavier Tekpli, Jürgen Geisler, Vessela N Kristensen, Arnoldo Frigessi, Aleix Prat, Alvaro Köhn-Luque
Computational model predicts patient outcomes in Luminal B breast cancer treated with endocrine therapy and CDK4/6 inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Irene Andreu-Saumell, Alba Rodriguez-Garcia, Vanessa Mühlgrabner, Marta Gimenez-Alejandre, Berta Marzal, Joan Castellsagué, Fara Brasó-Maristany, Hugo Calderon, Laura Angelats, Salut Colell, Mara Nuding, Marta Soria-Castellano, Paula Barbao, Aleix Prat, Alvaro Urbano-Ispizua, Johannes B Huppa, Sonia Guedan
CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition. Nature communications 15 (1) (2024)
Fara Brasó-Maristany, Gaia Griguolo, Nuria Chic, Tomás Pascual, Laia Paré, Julia Maues, Patricia Galván, Maria Vittoria Dieci, Federica Miglietta, Tommaso Giarratano, Olga Martínez-Sáez, Mercedes Marín-Aguilera, Francesco Schettini, Benedetta Conte, Laura Angelats, Maria Vidal, Barbara Adamo, Montserrat Muñoz, Esther Sanfeliu, Blanca González, Ana Vivancos, Patricia Villagrasa, Joel S Parker, Charles M Perou, PierFranco Conte, Aleix Prat, Valentina Guarneri
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1. Journal of the National Cancer Institute 115 (3) (2023)
Aleix Prat, Fara Brasó-Maristany, Adrienne G Waks, Esther Sanfeliu, Youli Xia, Meritxell Bellet-Ezquerra, Patricia Galván, Débora Martínez, Tomás Pascual, Mercedes Marín-Aguilera, Anna Rodríguez, Nuria Chic, Barbara Adamo, Laia Paré, María Jesús Vidal Losada, Mireia Margelí, Ester Ballana, Marina Gómez-Rey, Mafalda Oliveira, Eudald Felip, Judit Matito, Rodrigo Sánchez-Bayona, Anna Suñol, Cristina Saura, Eva Ciruelos, P Tolosa Ortega, Montserrat Muñoz, Blanca González-Farré, Patricia Villagrasa, Joel S Parker, Charles M Perou, Ana Vivancos
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer. Nature communications 14 (1) (2023)
Fara Brasó-Maristany, Gaia Griguolo, Nuria Chic, Tomás Pascual, Laia Paré, Julia Maues, Patricia Galván, Maria Vittoria Dieci, Federica Miglietta, Tommaso Giarratano, Olga Martínez-Sáez, Mercedes Marín-Aguilera, Francesco Schettini, Benedetta Conte, Laura Angelats, Maria Vidal, Barbara Adamo, Montserrat Muñoz, Esther Sanfeliu, Blanca González, Ana Vivancos, Patricia Villagrasa, Joel S Parker, Charles M Perou, PierFranco Conte, Aleix Prat, Valentina Guarneri
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1. Journal of the National Cancer Institute 115 (3) (2023)
Aleix Prat, Fara Brasó-Maristany, Adrienne G Waks, Esther Sanfeliu, Youli Xia, Meritxell Bellet-Ezquerra, Patricia Galván, Débora Martínez, Tomás Pascual, Mercedes Marín-Aguilera, Anna Rodríguez, Nuria Chic, Barbara Adamo, Laia Paré, María Jesús Vidal Losada, Mireia Margelí, Ester Ballana, Marina Gómez-Rey, Mafalda Oliveira, Eudald Felip, Judit Matito, Rodrigo Sánchez-Bayona, Anna Suñol, Cristina Saura, Eva Ciruelos, P Tolosa Ortega, Montserrat Muñoz, Blanca González-Farré, Patricia Villagrasa, Joel S Parker, Charles M Perou, Ana Vivancos
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer. Nature communications 14 (1) (2023)
Aleix Prat, Fara Brasó-Maristany, Adrienne G Waks, Esther Sanfeliu, Youli Xia, Meritxell Bellet-Ezquerra, Patricia Galván, Débora Martínez, Tomás Pascual, Mercedes Marín-Aguilera, Anna Rodríguez, Nuria Chic, Barbara Adamo, Laia Paré, María Jesús Vidal Losada, Mireia Margelí, Ester Ballana, Marina Gómez-Rey, Mafalda Oliveira, Eudald Felip, Judit Matito, Rodrigo Sánchez-Bayona, Anna Suñol, Cristina Saura, Eva Ciruelos, P Tolosa Ortega, Montserrat Muñoz, Blanca González-Farré, Patricia Villagrasa, Joel S Parker, Charles M Perou, Ana Vivancos
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer. Nature communications 14 (1) (2023)
Benedetta Conte, Luca Boni, Giancarlo Bisagni, Antonio Durando, Giovanni Sanna, Stefania Gori, Ornella Garrone, Stefano Tamberi, Sabino De Placido, Francesco Schettini, Antonio Pazzola, Riccardo Ponzone, Filippo Montemurro, Gianluigi Lunardi, Rosario Notaro, Maria De Angioletti, Anna Turletti, Mauro Mansutti, Fabio Puglisi, Antonio Frassoldati, Mauro Porpiglia, Alessandra Fabi, Daniele Generali, Giovanni Scognamiglio, Maura Rossi, Fara Brasó-Maristany, Aleix Prat, Barbara Cardinali, Patrizia Piccioli, Martina Serra, Sonia Lastraioli, Claudia Bighin, Francesca Poggio, Matteo Lambertini, Lucia Del Mastro
SNPs of aromatase predict long-term survival and aromatase inhibitor toxicity in patients with early breast cancer: a biomarker analysis of the GIM4 and GIM5 trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Fara Brasó-Maristany, Gaia Griguolo, Nuria Chic, Tomás Pascual, Laia Paré, Julia Maues, Patricia Galván, Maria Vittoria Dieci, Federica Miglietta, Tommaso Giarratano, Olga Martínez-Sáez, Mercedes Marín-Aguilera, Francesco Schettini, Benedetta Conte, Laura Angelats, Maria Vidal, Barbara Adamo, Montserrat Muñoz, Esther Sanfeliu, Blanca González, Ana Vivancos, Patricia Villagrasa, Joel S Parker, Charles M Perou, PierFranco Conte, Aleix Prat, Valentina Guarneri
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1. Journal of the National Cancer Institute 115 (3) (2023)
David Pesántez, Alberto Indacochea, Laura Angelats, Marianna Sirico, Iván Victoria, Esther Sanfeliu, Cristina Teixidó, Azucena E González-Navarro, Patricia Galván, Fara Brasó-Maristany, Pedro Jares, Manel Juan, Aleix Prat, Francesco Schettini, Javier García Corbacho
Unexpected Durable Complete Response With Anti-PD-L1 Blockade in Metastatic Undifferentiated Pleomorphic Sarcoma: A Case Report With Host and Tumor Biomarker Analysis. JCO precision oncology 7 (2023)
Aleix Prat, Fara Brasó-Maristany, Adrienne G Waks, Esther Sanfeliu, Youli Xia, Meritxell Bellet-Ezquerra, Patricia Galván, Débora Martínez, Tomás Pascual, Mercedes Marín-Aguilera, Anna Rodríguez, Nuria Chic, Barbara Adamo, Laia Paré, María Jesús Vidal Losada, Mireia Margelí, Ester Ballana, Marina Gómez-Rey, Mafalda Oliveira, Eudald Felip, Judit Matito, Rodrigo Sánchez-Bayona, Anna Suñol, Cristina Saura, Eva Ciruelos, P Tolosa Ortega, Montserrat Muñoz, Blanca González-Farré, Patricia Villagrasa, Joel S Parker, Charles M Perou, Ana Vivancos
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer. Nature communications 14 (1) (2023)
Anna Adam-Artigues, Enrique J Arenas Lahuerta, Alex Martínez-Sabadell, Fara Brasó-Maristany, Raimundo Cervera, Eduardo Tormo, Cristina Hernando, María Teresa Martínez Martínez, Juan Antonio Carbonell-Asins, Soraya Simón, Jesús Poveda, Santiago Moragón, Sandra Zazo, Débora Martínez, Ana Rovira, Octavio Burgués, Federico Rojo, Joan Albanell, Begoña Bermejo, Ana Lluch, Aleix Prat, Joaquín Arribas, Pilar Eroles, Juan Miguel Cejalvo
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer. Science advances 8 (20) (2022)
Adrienne G Waks, Anwesha Chaudhury, Nadia Solovieff, Laia Paré, Débora Martinez, Nuria Chic, Olga Martínez-Sáez, Fara Brasó-Maristany, Agnes Lteif, Tetiana Taran, Naveen Babbar, Fei Su
Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Phase III Studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (13) (2021)
Mònica Sánchez-Guixé, Cinta Hierro, José Jiménez, Cristina Viaplana, Guillermo Villacampa, Erika Monelli, Fara Brasó-Maristany, Zighereda Ogbah, Mireia Parés, Marta Guzmán, Judit Grueso, Olga Rodríguez, Mafalda Oliveira, Analía Azaro, Elena Garralda, Josep Tabernero, Oriol Casanovas, Maurizio Scaltriti, Aleix Prat, Rodrigo Dienstmann, Paolo G Nuciforo, Cristina Saura, Mariona Graupera, Ana Vivancos, Jordi Rodon, Violeta Serra
High FGFR1-4 mRNA Expression Levels Correlate with Response to Selective FGFR Inhibitors in Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Aleix Prat, Yi-Hsuan Tsai, Tomás Pascual, Laia Paré, Barbara Adamo, María Jesús Vidal Losada, Fara Brasó-Maristany, Patricia Galván, Jan Christoph Brase, Vanessa Rodrik-Outmezguine, Stephen Johnston, Eva Ciruelos Gil, Joel S Parker
A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor-positive HER2-negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)

Fara Brasó-Maristany.css-eqlu8i{font-size:small;padding-left:4px;} (Fara Brasó Maristany)

Publication Activity (10 Years)

Top Topics

Top Venues

Fara Brasó-Maristany (Fara Brasó Maristany)